Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth. (Q54302548)

27 May 2018

http://europepmc.org/abstract/MED/25500539

title

Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth. (English)

1 reference

27 May 2018

http://europepmc.org/abstract/MED/25500539

1 reference

1 reference

Hagit Eldar-Finkelman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

I Azoulay-Alfaguter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

R Elya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

L Avrahami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A Katz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

15 December 2014

1 reference

27 May 2018

http://europepmc.org/abstract/MED/25500539

published in

Oncogene

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

4613-4623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase 3: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK3 signalling in neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Targeting GSK-3: a promising approach for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase-3 and cancer: good cop, bad cop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase-3 and leukemia: restoring the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK3: a multifaceted kinase in Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The many ways of Wnt in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTOR in aging, metabolism, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTOR Signalling in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTOR, translation initiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Targeting the mTOR signaling network in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTOR inhibitors in advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Regulation of mammalian autophagy in physiology and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy and human disease: emerging themes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The dynamic nature of autophagy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy as a therapeutic target in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The paradox of autophagy and its implication in cancer etiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The autophagic paradox in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy fights disease through cellular self-digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

How to interpret LC3 immunoblotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

21 January 2018

The Beclin 1 interactome

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy suppresses tumorigenesis through elimination of p62

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Lysosomes: fusion and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Lysosomal function and dysfunction: mechanism and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Lysosomal positioning coordinates cellular nutrient responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The role of ubiquitylation in receptor endocytosis and endosomal sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Endocytosis and intracellular trafficking of ErbBs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Feedback regulation of EGFR signalling: decision making by early and delayed loops.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Inhibition of AMPK catabolic action by GSK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy suppresses tumor progression by limiting chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Induction of autophagy and inhibition of tumorigenesis by beclin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy-deficient mice develop multiple liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Mammalian autophagy: core molecular machinery and signaling regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK-3α is a central regulator of age-related pathologies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Cancer-associated lysosomal changes: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Defective acidification in human breast tumor cells and implications for chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Cluster analysis of an extensive human breast cancer cell line protein expression map database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Defective downregulation of receptor tyrosine kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

ErbB-targeted therapeutic approaches in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium/calpain signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

GSK3 and tau: two convergence points in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Autophagy in Human Health and Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

The phosphoinositide-3-kinase-Akt-mTOR pathway as a therapeutic target in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.390

Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice.

31 March 2020

1 reference

12 December 2020

1 reference

12 December 2020

Current state of mTOR targeting in human breast cancer

1 reference

12 December 2020

An overview of autophagy: morphology, mechanism, and regulation

1 reference

12 December 2020

Molecular cloning and expression of glycogen synthase kinase-3/factor A

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

11 June 2020

1022194028

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25500539%20AND%20SRC:MED&resulttype=core&format=json